Evaluating Small Cell Lung Cancer with PET-CT Scans Improves Survival | Lung Cancer Dispatch | Scoop.it

Accurately 'staging' small cell lung cancer (SCLC), that is, determining its extent and spread in a patient, is crucial in choosing treatment. One year after treatment guidelines began recommending positron emission tomography - computed tomography (PET-CT) instead of bone scans for the initial evaluation of all newly diagnosed SCLC patients, researchers confirmed that the new staging method improved outcomes. A study of SCLC patients diagnosed with limited-stage disease (ie, cancer that is confined to only one lung or its immediately surrounding tissue) showed that those who had received PET-CT staging before their treatment had higher 3-year survival rates (47% vs 19%) than those who did not.